Myeloid growth factors.
Publication
, Journal Article
Crawford, J; Allen, J; Armitage, J; Blayney, DW; Cataland, SR; Heaney, ML; Htoy, S; Hudock, S; Kloth, DD; Kuter, DJ; Lyman, GH; McMahon, B ...
Published in: J Natl Compr Canc Netw
August 1, 2011
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
August 1, 2011
Volume
9
Issue
8
Start / End Page
914 / 932
Location
United States
Related Subject Headings
- Risk Factors
- Risk Assessment
- Oncology & Carcinogenesis
- Neutropenia
- Neoplasms
- Myelodysplastic Syndromes
- Humans
- Fever
- Drug Therapy, Combination
- Cost-Benefit Analysis
Citation
APA
Chicago
ICMJE
MLA
NLM
Crawford, J., Allen, J., Armitage, J., Blayney, D. W., Cataland, S. R., Heaney, M. L., … National Comprehensive Cancer Network. (2011). Myeloid growth factors. J Natl Compr Canc Netw, 9(8), 914–932. https://doi.org/10.6004/jnccn.2011.0075
Crawford, Jeffrey, Jeffrey Allen, James Armitage, Douglas W. Blayney, Spero R. Cataland, Mark L. Heaney, Sally Htoy, et al. “Myeloid growth factors.” J Natl Compr Canc Netw 9, no. 8 (August 1, 2011): 914–32. https://doi.org/10.6004/jnccn.2011.0075.
Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, et al. Myeloid growth factors. J Natl Compr Canc Netw. 2011 Aug 1;9(8):914–32.
Crawford, Jeffrey, et al. “Myeloid growth factors.” J Natl Compr Canc Netw, vol. 9, no. 8, Aug. 2011, pp. 914–32. Pubmed, doi:10.6004/jnccn.2011.0075.
Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Steensma DP, Vadhan-Raj S, Westervelt P, Westmoreland M, National Comprehensive Cancer Network. Myeloid growth factors. J Natl Compr Canc Netw. 2011 Aug 1;9(8):914–932.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
August 1, 2011
Volume
9
Issue
8
Start / End Page
914 / 932
Location
United States
Related Subject Headings
- Risk Factors
- Risk Assessment
- Oncology & Carcinogenesis
- Neutropenia
- Neoplasms
- Myelodysplastic Syndromes
- Humans
- Fever
- Drug Therapy, Combination
- Cost-Benefit Analysis